| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |